These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29785325)

  • 1. Screening for malignant melanoma-a critical assessment in historical perspective.
    Weyers W
    Dermatol Pract Concept; 2018 Apr; 8(2):89-103. PubMed ID: 29785325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'epidemic' of melanoma between under- and overdiagnosis.
    Weyers W
    J Cutan Pathol; 2012 Jan; 39(1):9-16. PubMed ID: 22211330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management.
    Rhodes AR
    Med Clin North Am; 1986 Jan; 70(1):3-37. PubMed ID: 3510347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.
    Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R
    JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and histopathologic analyses of pigmented macular lesions on the soles of Japanese--proposal of a clinical guideline for detection of early malignant melanoma on the sole].
    Saida T; Yoshida N
    Nihon Hifuka Gakkai Zasshi; 1989 Feb; 99(2):117-28. PubMed ID: 2746966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
    Kittler H; Pehamberger H; Wolff K; Binder M
    J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forward to the Past-Oncology Between Underdiagnosis and Overtreatment.
    Weyers W
    Am J Dermatopathol; 2016 Jul; 38(7):517-28. PubMed ID: 27322786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for reducing morbidity and mortality in malignant melanoma.
    Johansson M; Brodersen J; Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012352. PubMed ID: 31157404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black and Brown Oro-facial Mucocutaneous Neoplasms.
    Natarajan E
    Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
    Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
    [No Abstract]   [Full Text] [Related]  

  • 12. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of the blue hue in dermoscopy of melanocytic lesions: a dermoscopic-pathologic study.
    Massi D; De Giorgi V; Carli P; Santucci M
    Am J Dermatopathol; 2001 Oct; 23(5):463-9. PubMed ID: 11801781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
    Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
    JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital nevocytic nevi and malignant melanomas.
    Kopf AW; Bart RS; Hennessey P
    J Am Acad Dermatol; 1979 Aug; 1(2):123-30. PubMed ID: 391836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of screening on melanoma incidence and biopsy rates.
    Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
    Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
    Shoo BA; Sagebiel RW; Kashani-Sabet M
    J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.